The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nonclinical safety assessment of AMG 553, an investigational anti-FLT3 CAR-T therapy.
 
Christine M Karbowski
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Rebecca Goldstein
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Brendon Frank
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Kei Kim
Employment - Amgen; Gilead Sciences
Stock and Other Ownership Interests - Amgen
 
Chi-Ming Li
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Bradford Gibson
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Oliver Homann
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Patents, Royalties, Other Intellectual Property - Amgen
 
Kelly Hensley
Employment - Amgen; Seagen
Stock and Other Ownership Interests - Amgen
 
Ben Brooks
Employment - Amgen
Stock and Other Ownership Interests - Amgen; Baxter/Baxalta/Shire
 
Qinghong Yan
Employment - Amgen; Philips Healthcare (I)
Stock and Other Ownership Interests - Amgen; Philips Healthcare (I)
 
Rocio Hernandez
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Gregor Adams
Employment - Kite/Gilead
Stock and Other Ownership Interests - Kite/Gilead
Patents, Royalties, Other Intellectual Property - Kite/Gilead
 
Michael C Boyle
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Tara Lynn Arvedson
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Herve Lebrec
Employment - Amgen
Stock and Other Ownership Interests - Amgen